ONWD — ONWARD Medical Share News
0.000.00%
Last trade - 00:00- €163.04m
- €95.33m
- €3.78m
Brief: Ottobock Invests EUR 10 Million In Onward Medical
Brief: Bookrunner Says Onward Medical Primary ABB Books Covered, Further Guidance To Follow
Brief: ONWARD Medical Receives FDA De Novo Classification
Brief: Onward Medical Says Receives FDA De Novo Classification And US Market Authorization For ARC-EX System
Brief: Onward Medical Obtains Debt Financing With Up To €52.5 Million Secured Loan From Runway Growth Capital Llc
Brief: Onward Medical End-March Cash And Cash Equivalents At EUR 42.0 Mln
Brief: Onward Medical Says Arc-Ex Therapy Study Achieved All Primary Safety & Effectiveness Endpoints
Brief: Onward Medical Says Has A Cash Runway Through Mid-2025
Brief: Onward Medical Submits De Novo Application To FDA For Its Arc-Ex® System
Brief: Onward Medical: Closing Of Accelerated Bookbuild Offering And Public Offering In France
Brief: Onward Medical Raises EUR 20 Mln In Capital Increase
Brief: Onward Medical Issues Eur 15 Million New Shares Via An Accelerated Bookbuilding
Brief: Onward Medical Sees FDA Submission For ARC-EX System In H1 2024
Brief: Onward Medical Accepted To FDA Program For Development Of ARC-BCI System
Brief: Onward Medical Awarded Device Designation For Brain-Computer Interface From US FDA
Brief: Onward Medical Announces Start Of HemON NL Clinical Study
Brief: Onward Medical Reaffirms Its Expected Cash Runway Through End Of 2024
Brief: Onward Medical Announces Successful First-In-Human Implant Of Its ARC-IM Stimulator To Restore Upper Extremity Function After Spinal Cord Injury
Brief: ONWARD Medical H1 Net Loss Widens To EUR 19.2 Million, CFO Steps Down